Invitrogen™ ELISA mouse kit

Ref.: BL-RE-091588Manufacturer ref.: EM61RBX10 10 x 96 tests
Price on request
Custom pricing depending on configuration and quantity.

PDGF was found to be a major mitogenic factor present in serum but absent in plasma. It is secreted by the alpha granules of the platelets, activated during blood clotting to form serum. Studies have shown...

Accession number
P20033
Dose range
3.2 to 800 pg/ml
Sensitivity of the dosage
3.2 pg/ml
Conjugate
Biotin
Product type
ELISA
Brand
Invitrogen

PDGF was found to be a major mitogenic factor present in serum but absent in plasma. It is secreted by the alpha granules of the platelets, activated during blood clotting to form serum. Studies have shown...

PDGF was found to be a major mitogenic factor present in serum but absent in plasma. It is secreted by the alpha granules of the platelets, activated during blood clotting to form serum. Studies have shown that PDGF did not correspond to one but to three molecules, each being a dimeric combination of two distinct but structurally related peptide chains called A and B. Dimeric isoforms PDGF-AA, AB, and BB are expressed differentially in various cell types and their effects are mediated by two distinct receptors, alpha and beta. There are differences in the binding of these isoforms to each receptor. In general, PDGF isoforms are potent mitogens for connective tissue cells, including dermal fibroblasts, glial cells, arterial smooth muscle cells, and certain epithelial and endothelial cells. In addition to its mitogen activity, PDGF is chemotactic for fibroblasts, smooth muscle cells and mononuclear cells. Other reported activities include stimulation of granule release by neutrophils and monocytes, facilitation of steroid synthesis by Leydig cells, stimulation of neutrophil phagocytosis, inhibition of natural killer cell activity (NK), modulation of thrombospondin expression and secretion, stimulation of collagenase activity and secretion and transient induction of T-cell secretion of IL-2, accompanied by decreasing regulation of the production of IL-4 and d-IFN-gamma, temporary effects that may allow the clone expansion of Auxiliary B and T lymphocytes activated by antigen prior to differentiation

Sensitivity

Sensitivity of dosage: 3.2 pg/ml.

Measurement range

Dose range: 3.2 to 800 pg/ml.

Duration of dosing

Total duration of dosing: 4 h 45 min.

Reproducibility

Coefficient of intradose variation < 10%, interdose < 12%.

Target

Target: PDGF-AA.

Technical specifications

General
BrandInvitrogen
Supplier ref. (Fisher Scientific)17798073
Specifications
Accession numberP20033
Dose range3.2 to 800 pg/ml
Sensitivity of the dosage3.2 pg/ml
ConjugateBiotin
Product typeELISA
Type of samplePlasma, Serum, Surnatant
For use with (equipment)Colorimetric microplate reader
Genetic identification (Enter)18590
Gene symbol(s)Pdgfa
Coefficient of inter-dose variation< 12%
Coefficient of intra-dose variation< 10%
Contents of kits96-well pre-coated sheetings, etc., at the same time as the pre-casting plate, at the same time as the pre-casting plate.
Marker or dyeHRP
Quantity10 x 96 tests
Regulatory statusRUO
TargetPDGF-AA
Test time1 h 20 min
Physical characteristics
Volume of sampleSerum, 50 μl-Plasma, 50 μl-Surnatant, 50 μl
Storage and shipping
Storage conditions2°C to 8°C
Total duration of dosing4 h 45 min

Origin and customs

Manufacturer ref.EM61RBX10
Country of originUnited States
HS customs code3002 12 00 00
A question or a specific configuration?
Contact us for a quote.